According to the NCI bexarotene is a synthetic retinoic acid agent with potential antineoplastic, chemopreventive, teratogenic and embryotoxic properties.

Indikationen/Anwendungsmöglichkeiten gemäss Chemocare.com:
Cutaneous T-cell lymphoma (mycosis fungoides) in patients who have not responded to at least one previous treatment regimen.

Link to MedlinePlus, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute
Link zu Wiki
Link to Physicians Desk Reference (PDR)
Link to European Medicines Agency (EMEA)
Info for Patients presented by Scott Hamilton from Chemocare.com